WHO recommendations on antenatal care for a positive pregnancy experience

Recommendations

Info

<strong>WHO</strong> <strong>recommendations</strong> on antenatal care for a positive pregnancy experience <strong>WHO</strong> guideline title Year of publication <strong>WHO</strong> department responsible Approach 12. Systematic screening for active tuberculosis: principles and <strong>recommendations</strong> 2013 Strategic and Technical Advisory Group for Tuberculosis Recommendation relevant to ANC was integrated into the ANC guideline. 13. <strong>WHO</strong> <strong>recommendations</strong> for the prevention and management of tobacco use and second-hand smoke exposure in pregnancy 2013 Department of Prevention of Noncommunicable Diseases Recommendations relevant to ANC were integrated into the ANC guideline. 14. Guidelines for the identification of substance use and substance use disorders in pregnancy 2014 Department of Mental Health and Substance Abuse Recommendation relevant to ANC was integrated into the ANC guideline. 15. <strong>WHO</strong> <strong>recommendations</strong> on community mobilization through facilitated participatory learning and action cycles with women’s groups for maternal and newborn health 2014 MCA Referenced 16. Guidelines for the treatment of malaria 2015 Global Malaria Programme Recommendation relevant to ANC was integrated into the ANC guideline. 17. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV 2015 Department of HIV Recommendation relevant to ANC was integrated into the ANC guideline. 18. Consolidated guidelines on HIV testing services 2015 Department of HIV Recommendation relevant to ANC was integrated into the ANC guideline. 19. <strong>WHO</strong> <strong>recommendations</strong> for prevention and treatment of maternal peripartum infections 2015 RHR Referenced 20. <strong>WHO</strong> <strong>recommendations</strong> on health promotion interventions for maternal and newborn health 2015 MCA Referenced and cross-checked for consistency 21. Guideline: preventive chemotherapy to control soiltransmitted helminths in high-risk groups 2016 <strong>WHO</strong> Evidence and Programme Guidance Unit, NHD, Preventive Chemotherapy and Transmission Control, Department of Control of Neglected Tropical Diseases Referenced and cross-checked for consistency 142
Annex 3: Summary of declarations of interest from the Guideline Development Group (GDG) members and how they were managed Name Expertise Disclosure of interest Conflict of interest and management Dr Ariful Alam Nutrition, health systems None declared Not applicable Dr Françoise Cluzeau Evidence synthesis and guideline development using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach None declared Not applicable Dr Luz Maria De-Regil Nutrition, epidemiology, systematic reviews, programme implementation Full staff employee of the Micronutrient Initiative and part of the working group that advised on the International Federation of Gynecology and Obstetrics (FIGO) <strong>recommendations</strong> on nutrition. The conflict was not considered serious enough to affect GDG membership or participation in the Technical Consultation. Dr Atf Ghérissi Systematic reviews, qualitative evidence, maternal and perinatal health, community health None declared Not applicable Mrs Gill Gyte Patient representative, pregnancy and childbirth Voluntary work for the Cochrane Pregnancy and Childbirth Group, which is funded by United Kingdom Department of Health. The conflict was not considered serious enough to affect GDG membership or participation in the Technical Consultation. Dr Rintaro Mori Perinatology, neonatology, systematic reviews, evidence synthesis and guideline development using GRADE None declared Not applicable Prof. Jim Neilson General obstetrics, perinatology, gynaecology, systematic reviews, evidence synthesis and guideline development using GRADE None declared Not applicable Dr Lynnette Neufeld Micronutrients, programmes, epidemiology Previous employer received funding from the Canadian Government to design and implement iron/folic acid and other programmes related to nutrition during pregnancy; designed demonstration projects with local partners and academic institutions to integrate nutrition actions into antenatal care (ANC). The conflict was not considered serious enough to affect GDG membership or participation in the Technical Consultation. Prof. Nafissa Osman Obstetrics and gynaecology, implementation research None declared Not applicable Prof. Bob Pattinson Obstetrics and gynaecology, delivery of care, evidence synthesis None declared Not applicable Annex 3: Summary of declarations of interest 143
Page 1:
WHO recomm
Page 4 and 5:
WHO Library Catalo
Page 6 and 7:
« To achieve the Every Woman Every
Page 8 and 9:
Funding was provided for this guide
Page 10 and 11:
WHO recomm
Page 12 and 13:
Evaluation (GRADE) and Confidence i
Page 14 and 15:
Zinc supplements Multiple micronutr
Page 16 and 17:
Ultrasound scan Doppler ultrasound
Page 18 and 19:
Task shifting components of antenat
Page 20 and 21:
expect from ANC is to have a “pos
Page 22 and 23:
2. Methods WHO <st
Page 24 and 25:
a list of ANC outcomes was prioriti
Page 26 and 27:
content experts among the GDG membe
Page 28 and 29:
• nFeasibility: Feasibility is in
Page 30 and 31:
are indicated by a footnote in the
Page 32 and 33:
A. Nutritional interventions <stron
Page 34 and 35:
WHO recomm
Page 36 and 37:
A.1.2: Nutrition education on energ
Page 38 and 39:
A.1.3: Energy and protein dietary s
Page 40 and 41:
A.1.4: High-protein supplements REC
Page 42 and 43:
WHO recomm
Page 44 and 45:
Summary of evidence and considerati
Page 46 and 47:
WHO recomm
Page 48 and 49:
WHO recomm
Page 50 and 51:
Equity Effective interventions to i
Page 52 and 53:
A.7: Vitamin B6 (pyridoxine) supple
Page 54 and 55:
only a quarter of the planned sampl
Page 56 and 57:
A.10: Restricting caffeine intake R
Page 58 and 59:
B. Maternal and fetal assessment B.
Page 60 and 61:
WHO recomm
Page 62 and 63:
to produce results than urine dipst
Page 64 and 65:
WHO recomm
Page 66 and 67:
B.1.4: Gestational diabetes mellitu
Page 68 and 69:
B.1.6: Substance use RECOMMENDATION
Page 70 and 71:
on screening, please refer to the 2
Page 72 and 73:
Women’s values A scoping review o
Page 74 and 75:
B.2.2: Symphysis-fundal height (SFH
Page 76 and 77:
B.2.4: Ultrasound scan RECOMMENDATI
Page 78 and 79:
WHO recomm
Page 80 and 81:
are willing to be screened and test
Page 82 and 83:
Women’s values A scoping review o
Page 84 and 85:
WHO recomm
Page 86 and 87:
C.4: Preventive anthelminthic treat
Page 88 and 89:
C.5: Tetanus toxoid vaccination REC
Page 90 and 91:
C.6: Intermittent preventive treatm
Page 92 and 93:
D. Interventions for common physiol
Page 94 and 95:
WHO recomm
Page 96 and 97:
Values See “Women’s values” a
Page 98 and 99:
D.4: Interventions for low back and
Page 100 and 101:
Acceptability Qualitative evidence
Page 102 and 103:
Additional considerations • nComp
Page 104 and 105:
WHO recomm
Page 106 and 107:
Senegal, Sri Lanka, Yemen and Zambi
Page 108 and 109:
WHO recomm
Page 110 and 111: WHO recomm
Page 116 and 117: may help to address inequalities. H
Page 118 and 119: E.6: Recruitment and retention of s
Page 122 and 123: visits (high confidence in the evid
Page 136 and 137: 5. Research implications During the
Page 138 and 139: 6. Dissemination, applicability and
Page 140 and 141: espectively. Any concern about the
Page 148 and 149: 105. Systematic screening for activ
Page 158 and 159: WHO headquarters (
Page 162 and 163: Dr Erika Ota Nutrition, evidence sy
Page 170: WHO recomm
show all

WHO recommendations on antenatal care for a positive pregnancy experience

Create successful ePaper yourself

Delete template?

Save as template?